Status:
COMPLETED
sgp130 in Chronic Human Liver Disease
Lead Sponsor:
Erasme University Hospital
Conditions:
Alcoholic Liver Disease
Chronic Hepatitis C Virus Infection
Eligibility:
All Genders
18+ years
Brief Summary
Chronic liver disease are characterized by increased levels of plasma IL-6, but the bioactivity of this cytokine in this disease is not well known. IL-6 receptor complex is regulated by multiple recep...
Detailed Description
Consecutive patients undergoing transjugular liver biopsies for alcoholic liver disease or hepatitis C virus infection will be included in the study to measure plasma cytokines levels, peripheral bloo...
Eligibility Criteria
Inclusion
- Alcohol excess intake and suspected liver disease
- Alcohol excess intake and clinical liver cirrhosis
- chronic hepatitis C virus infection and suspected liver disease
- chronic hepatitis C virus infection and clinical liver cirrhosis
Exclusion
- other (superimposed) liver disease
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT00770198
Start Date
January 1 2005
End Date
October 1 2008
Last Update
October 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Erasme - Dpt of Gastroenterology
Brussels, Belgium, 1070